Chemistry: molecular biology and microbiology – Differentiated tissue or organ other than blood – per se – or...
Reexamination Certificate
2011-03-01
2011-03-01
Long, Scott (Department: 1633)
Chemistry: molecular biology and microbiology
Differentiated tissue or organ other than blood, per se, or...
C514S571000, C514S049000
Reexamination Certificate
active
07897326
ABSTRACT:
Methods and compositions for reducing, preventing or reversing organ damage and/or enhancing organ preservation by administration of a peroxisome-proliferator activated receptor-alpha (PPARα) agonist to the organ.
REFERENCES:
patent: 5834178 (1998-11-01), Churchill et al.
patent: 6187814 (2001-02-01), Elias et al.
patent: 0455042 (1991-11-01), None
patent: 1 621 200 (2006-02-01), None
patent: 2004-339068 (2004-12-01), None
patent: WO 02/34259 (2002-05-01), None
patent: WO 03/059294 (2003-07-01), None
patent: WO 03/075911 (2003-09-01), None
patent: WO 2005/047268 (2005-05-01), None
Weiner et al (J Gen Intern Med. 2004; 19: 1045-1052).
Kind et al. (Wisconsin Medical Journal. 2002; 101(7): 53-56).
Jackson et al. (European Society for Organ Transplantation. 2007; 20: 277-290).
International Search Report dated Mar. 26, 2008, in PCT/US2007/064198.
Jackson et al.,Transplant International, 20: 277-290 (2007).
Muller et al.,American Journal of Pathology, 164(2): 521-532 (Feb. 2004).
Written Opinion of the International Searching Authority dated Mar. 26, 2008, in PCT/US2007/064198.
Bastani et al., “Post-Transplant Hyperlipidemia: Risk Factors and Response to Dietary Modification and Gemfibrozil Therapy,”Clinical Transplantation, 9: 340-348 (1995).
Bolz et al., “Intact Endothelial and Smooth Muscle Function in Small Resistance Arteries After 48 h in Vessel Culture,”American Journal of Physiology, 279(3): H1434-H1439 (Sep. 2000).
Briére, “Human Foetal Kidney Explants in Serum-Free Organ Culture,”Anatomy and Embryology, 176(1): 105-114 (1987).
Cerilli et al., “Effect of Mannitol, Saline, and Urea on the Function of a Recently Autotransplanted Kidney,”Archives of Surgery, 92: 178-183 (Feb. 1966).
Chan et al., “Hyperlipidemia After Renal Transplantation: Treatment With Gemfibrozil,”Nephron, 67(3): 317-321 (Jul. 1994).
Cuzzocrea et al., “Role of Endogenous and Exogenous Ligands for the Peroxisome Proliferators Activated Receptors Alpha (PPAR-α) in the Development of Inflammatory Bowel Disease in Mice,”Laboratory Investigation, 84: 1643-1654 (2004).
Dishart et al., “An Evaluation of Pharmacological Strategies for the Prevention and Treatment of Acute Renal Failure,”Drugs, 59(1): 79-91 (Jan. 2000).
Dubey et al., “Nitric Oxide Inhibits Angiotensin II-Induced Migration of Rat Aortic Smooth Muscle Cell,”The Journal of Clinical Investigation, 96(1): 141-149 (Jul. 1995).
Dubey et al., “Smooth Muscle Cell-Derived Adenosine Inhibits Cell Growth,”Hypertension, 27(No. 3, Pt. 2): 766-773 (Mar. 1996).
Dubey et al., “Exogenous and Endogenous Adenosine Inhibits Fetal Calf Serum-Induced Growth of Rat Cardiac Fibroblasts,”Circulation, 96(8): 2656-2666 (Oct. 21, 1997).
Dubey et al., “Estrogen and Tamoxifen Metabolites Protect Smooth Muscle Cell Membrane Phospholipids Against Peroxidation and Inhibit Cell Growth,”Circulation Research, 84(2): 229-239 (Feb. 5, 1999).
Dubey et al., “Methoxyestradiols Mediate the Antimitogenic Effects of Estradiol on Vascular Smooth Muscle Cells via Estrogen Receptor-Independent Mechanisms,”Biochemical and Biophysical Research Communications, 278(1): 27-33 (Nov. 11, 2000).
Duez et al., “Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor α Modulation,”Arteriosclerosis, Thrombosis, and Vascular Biology, 25(3): 585-591 (Mar. 2005).
Fang et al., “Activation of Peroxisome Proliferator-Activated Receptor α by Substituted Urea-Derived Soluble Epoxide Hydrolase Inhibitors,”The Journal of Pharmacology and Experimental Therapeutics, 314(1): 260-270 (2005).
Gao et al., “α2-Adrenoceptors Potentiate Angiotensin II- and Vasopressin-Induced Renal Vasoconstriction in Spontaneously Hypertensive Rats,”The Journal of Pharmacology and Experimental Therapeutics, 305(2): 581-586 (2003).
Grino et al., “Flush Solution With Mannitol in the Prevention of Post-Transplant Renal Failure,”Transplantation Proceedings, XIX(5): 4140-4142 (Oct. 1987).
Herrero et al., “Evaluation of a Preservation Solution Containing Fructose-1,6-Diphosphate and Mannitol Using the Isolated Perfused Rat Kidney, Comparison with Euro-Collins and University of Wisconsin Solutions,”Nephrology Dialysis Transplantation, 10(4): 519-526 (1995).
Izzedine et al., “Renal Effects of PPARα-Agonists,”Minerva Urologica E Nefrologica, 56(4): 339-342 (Dec. 2004).
Jackson et al., “Phosphodiesterases in the Rat Renal Vasculature,”Journal of Cardiovascular Pharmacology, 30(6): 798-801 (Dec. 1997).
Jackson et al., “Modulation of Cyclic AMP Production by Signal Transduction Pathways in Preglomerular Microvessels and Microvascular Smooth Muscle Cells,”The Journal of Pharmacology and Experimental Therapeutics, 310(1): 349-358 (Jul. 2004).
Jackson et al., “Mechanism of the Vascular Angiotensin II/α2-Adrenoceptor Interaction,”The Journal of Pharmacology and Experimental Therapeutics, 314(3): 1109-1116 (Sep. 2005).
Jacobson et al., “Diuretics: Sites and Mechanisms of Action,”Annual Review of Pharmacology and Toxicology, 16: 201-214 (1976).
Kasiske et al., “The Effects of Lipid-Lowering Agents on Acute Renal Allograft Rejection,”Transplantation, 72(2): 223-227 (Jul. 27, 2001).
Kline et al., “High Osmolality-Low pH Flush Solutions Improve Renal Transplant Function in Rats,”Urological Research, 19(2): 81-86 (1991).
Lane et al., “Effect of Mannitol and Polyethylene Glycol on the Action of Frusemide During Renal Storage and Transplantation,”Transplantation, 62(5): 575-582 (Sep. 15, 1996).
Lopez-Costea et al., “Solucion De Manitol (M-400) Versus Solucion De Manitol Y Alopurinol En La Prevencion Del Fracaso Renal Agudo Post-TR,”Actas Urologicas Españolas, 16(6): 446-450 (Jun. 1992).
Mi et al., “Metabolism of Exogenous Cyclic AMP to Adenosine in the Rat Kidney,”The Journal of Pharmacology and Experimental Therapeutics, 273(2): 728-733 (May 1995).
Mi et al., “Evidence for an Endogenous cAMP-Adenosine Pathway in the Rat Kidney,”The Journal of Pharmacology and Experimental Therapeutics, 287(3): 926-930 (Dec. 1998).
Mi et al., “Effects of α- and β-Adrenoceptor Blockade on Purine Secretion Induced by Sympathetic Nerve Stimulation in the Rat Kidney,”The Journal of Pharmacology and Experimental Therapeutics, 288(1): 295-301 (Jan. 1999).
Mouthiers et al., “Peroxisome Proliferator-Activated Receptor α Physically Interacts with CCAAT/Enhancer Binding Protein (C/EBPβ) to Inhibit C/EBPβ-Responsive α1-Acid Glycoprotein Gene Expression,”Molecular Endocrinology, 19(5): 1135-1146 (May 2005).
Nissenson et al., “Mannitol,”The Western Journal of Medicine, 131(4): 277-284 (Oct. 1979).
Nydegger et al., “New Concepts in Organ Preservation,”Transplant Immunology, 9: 215-225 (2002).
Ren et al., “PPARα Activation Upregulates Nephrin Expression in Human Embryonic Kidney Epithelial Cells and Podocytes by a Duel Mechanism,”Biochemical and Biophysical Research Communications, 338(4): 1818-1824 (Dec. 30, 2005).
Strakova et al., “Peroxisome Proliferator-Activated Receptors (PPAR) Agonists Affect Cell Viability, apoptosis and Expression of Cell Cycle Related Proteins in Cell Lines of Glial Brain Tumors,”Neoplasma, 52(4): 126-136 (2005).
Tiggeler et al., “Prevention of Acute Tubular Necrosis in Cadaveric Kidney Transplantation by the Combined Use of Mannitol and Moderate Hydration,”Annals of Surgery, 201(2): 246-251 (Feb. 1985).
Töröner et al., “Effects of PPARγ and PPARα Agonists on Serum Leptin Levels in Diet-Induced Obese Rats,”Hormone and Megabolic Research, 36: 226-230 (Apr. 2004).
Van Raalte et al., “Peroxisome
Jackson Edwin K.
Jackson Travis Corey
Mi Zaichuan
Leydig , Voit & Mayer, Ltd.
Long Scott
University of Pittsburgh-of the Commonwealth System of Higher Ed
LandOfFree
Peroxisome-proliferator activated receptor-alpha agonists... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peroxisome-proliferator activated receptor-alpha agonists..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peroxisome-proliferator activated receptor-alpha agonists... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2673624